{
  "Q0": "Whole genome sequencing (WGS)",
  "Q1": "Yes",
  "Q2": "No",
  "Q3": "No",
  "Q4": "Yes",
  "Q4_1": "Yes",
  "Q4_1_1": "ACMG",
  "Q5": "No",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8_1": "Targeted gene panel or chromosomal microarray (CMA)",
  "Q9": "Yes",
  "Q9_1": "No",
  "Q10": "No",
  "Q10_1": "Diagnostic",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14_1": "81425",
  "Q15": "No",
  "Q16": "No",
  "Q17": "Based on the policy, this test would not be covered, so no claim submission steps are applicable. If the provider wishes to pursue testing, they would need to first perform more targeted testing (such as CMA), document more severe clinical features that meet policy criteria, and have the test ordered by an appropriate specialist (medical geneticist, neonatologist, neurologist, or developmental pediatrician).",
  "match": true
}